Crossmark

Efficacy and safety of alemtuzumab treatment in a real-world cohort of patients with multiple sclerosis

Published Online: 2020-05-23

Published Print: 2021-12

Authors

Zmira, Ofir https://orcid.org/0000-0002-4798-7194
Halpern, Alex I.

Abraham, Lital

Achiron, Anat
License Information

Text and Data Mining valid from 2020-05-23

Version of Record valid from 2020-05-23
More Information

Article History

Received: 21 January 2020

Accepted: 12 May 2020

First Online: 23 May 2020

Compliance with ethical standards

:

: The authors declare that they have no conflicts of interest.

: The study was conducted after approval of the ethics committee of Sheba Medical Center in accordance with the Declaration of Helsinki.

Document is current